Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net revenue	$ 1,102,321	$ 950,294
Cost of sales (exclusive of amortization shown separately below)	493,353	403,110
Amortization of acquired intangible assets	8,908	6,374
Total cost of sales	502,261	409,484
Gross profit	600,060	540,810
Operating Expenses
Selling, general, and administrative	222,874	193,933
Research and development	75,710	63,188
Amortization of acquired intangible assets	12,479	7,950
Total operating expenses	311,063	265,071
Income from operations	288,997	275,739
Other income (loss), net:
Interest (expense) income, net	(14,957)	(7,134)
Loss attributable to equity method investments (note 5)	(3,895)	(2,028)
Gain (loss) on equity investments (note 5)	(602)	(3,280)
Other, net	2,648	(1,504)
Total other income (loss), net	(16,806)	(13,946)
Income before income taxes	272,191	261,793
Income taxes	52,769	51,315
Net income	$ 219,422	$ 210,478
Basic earnings per share (in dollars per share)	$ 1.49	$ 1.44
Diluted earnings per share (in dollars per share)	1.49	1.43
Dividend declared per share (in dollars per share)	$ 0.48	$ 0.44
Basic shares outstanding (000's) (in shares)	147,075	146,431
Diluted shares outstanding (000's) (in shares)	147,486	147,134
Total Sleep and Respiratory Care
Net revenue	$ 963,037	$ 844,443
Cost of sales (exclusive of amortization shown separately below)	444,460	363,844
Amortization of acquired intangible assets	1,916	1,228
Software as a Service
Net revenue	139,284	105,851
Cost of sales (exclusive of amortization shown separately below)	48,893	39,266
Amortization of acquired intangible assets	$ 6,992	$ 5,146